SlideShare une entreprise Scribd logo
1  sur  3
Bum Kim, M.S.
Suwanee, GA 30024 (510) 709 - 7441
www.linkedin.com/in/bumkim bryantbumkim@yahoo.com
OBJECTIVE
To pursue a challenging career in Drug, Biologics, and Medical Device Regulatory Affairs and become a part of an
esteemed organization where I can use my skills, knowledge and experience to contribute in DMRs,Technical files,
Design Dossiers, IND application/EUA documents, CAPA, CMC compilation, QSR’s, ISO, CRFs, Clinical Study
Monitoring, ICH/GCP guidelines and Project Planning to the growth of the organization.
SUMMARY
 Accustomed to working with project teams and providing research and advice on compliance with federallaws
and FDA/USDA regulatory agency guidelines, SOP preparation, updated good laboratory practices.
 Strong knowledge of Medical Device Reporting (MDRs), Medical Vigilance Reporting (MDVs), risk
management, validations, design controls, process development, monitoring, statistical controls and root cause
analysis.
 Participated in audits performed by internal and external representatives for ISO and FDA compliance.
 Familiarity with the drug and medical device development process – cGMP (DMF), GLP, GCP, QSR, IND,
NDA, BLA, 510K, PMA, Informed Consent, IRB review, and ethical principles (Belmont Report) in clinical
research.
 Solid working experience in the pharmaceutical industry – New Drug Discovery Research.
 Familiarity with standard concepts, practices, and procedures within a biotech/life sciences field.
 Methodical, quick-learner and highly independent team player, problem solver and can troubleshoot any
scientific issues.
 Ability to multi-task and to establish and maintain good working relationships at all levels.
 Strategic thinker with strong attention to detail and with excellent communication skills.
EDUCATION
Northeastern University Boston, MA
Master of Science in Regulatory Affairs September 2015
Concentration in Drugs, Biologics and Medical Devices,GPA: 3.6 (4.0)
Relevant Courses: Drug and Medical Device Regulation, Human Experimentation, New Drug Development:
Regulatory Overview, Medical Device Development: Regulatory Overview, Food, Drug, & Medical Device Law,
Biologics Development: Regulatory Overview, Adv. & Promo of Drugs and Medical Device Products,Clinical Drug
Data Analysis.
University ofMemphis Memphis, TN
Master of Science in Organic Chemistry,GPA: 3.3 (4.0) December 2001
Relevant Courses: Inorganic Chemistry, Advanced Instrumental Analysis, Intermediate Organic Chemistry,
Heterocyclic Chemistry, Advanced Organic Chemistry, Physical Chemistry, Advanced Physical Chemistry, Synthetic
Organic Chemistry, Advanced Analytical Chemistry, Approximate Chemical Modeling Methods.
Activities:
 Research Assistant – Studied molecular design and molecular recognition of xanthine based nucleosides
leading to the isolation and characterization of xanthine nucleosides.
 Teaching Assistant – Taught general chemistry and organic chemistry labs.
 Coordinated laboratory materials, conducted lab sessions, and graded lab reports.
WORK EXPERIENCE
SUPRA SCIENCES Atlanta, GA
Technical Sales Scientist June 2015 – Current
 Handled Company accounts as a direct line to sales and technical support.
 Helped to support regulatory compliance throughout the organization.
 Travelled to large pharmaceutical companies and academic institutions for company product presentation
and field action activities.
CPC SCIENTIFIC Sunnyvale, CA
Technical Sales Account Manager March 2013 – May 2014
 Managed company’s peptide and research product portfolio.
 Performed other job related duties as required, e.g. managing company accounts.
 Updated and analyzed strategic accounts within the territory.
 Established relationships with clients through phone conversations and compiled a list of valuable accounts.
Utilized interpersonal and communication skills to develop these relationships and close the deal.
ANASPEC Fremont, CA
Technical Inside Sales April 2012 – February 2013
 Managed and promoted sales of company’s products; 12,000 catalog proteomics and genomic products
(peptides, antibodies, dyes, assay kits, unusual amino acids, q-PCR),as well as custom made products.
 Coordinated and ensured quality control process by working with QC/QA dept. – compliance with SOP.
 Enhanced organizational effectiveness through inter-dept. relationship (production, purification, QC/QA,
Sales & Marketing departments). Worked with multi-national individuals and companies.
 Supported the implementation of regulatory activities throughout the facility.
NOVABAYPHARMACEUTICALS Emeryville, CA
Senior Research Associate March 2008 – September2011
 Produced a series of N-Chloroamine analogs (Aganocide) for biological screening and stability leading to the
identification of highly broad-spectrum biological activity with excellent stability profile.
 Participated in drug design and syntheses of different classes of Anti-infective such as LpxC, DNA Ligase
and Oxazolidinone compounds, which resulted in excellent antibacterial activity.
 Co-inventor of key patents for Aganocide compounds with NovaBay Pharmaceuticals.
CHEMOCENTRYXPHARMACEUTICALS Mountain View, CA
Senior Associate Scientist August 2007 – March 2008
 Produced first lead series that validated the project, leading to the discovery of highly potent CCR2
chemokine receptors.
 Identified early generation of biologically-active chemokine receptor compounds for screening purposes with
improved CYP and PK profile by multi-step organic synthesis.
SUNESIS PHARMACEUTICALS South San Francisco, CA
Staff Research Associate II December 2005 – July 2007
 Contributed in design and synthesis of novel kinase inhibitors (Aurora, RAF and BTK) for anti-cancer and
anti-inflammatory agents.
 Produced key leads with improved potency and safety.
PFIZER INC. / VICURON PHARMACEUTICALS Fremont, CA
Scientist III March 2003 – November2005
 Co-invented key patent on the novel Ramoplanin derivatives possessing antibacterial activity.
 Independently designed and implemented multi-step synthetic syntheses of key lead compounds.
 Prepared and purified modified natural products (Polymyxin B, Ramoplanin and Pleuromutilin) improved in
toxicity profile and biological activity.
Scientist II November 2001 – February 2003
 Contributed to pre-clinical discovery of novel anti-infective drugs, including antibacterial (Ramoplanin,
Pleuromutilin) and antifungal (Polymyxin B) projects.
 Analyzed and prepared compounds for screening by multi-step organic synthesis that included the lead
compound identification in the project.
RELEVANT SKILLS
 Languages: Fluent in English and Korean.
 Computer skills: Proficient in MS Word, Excel, PowerPoint, MS Project, Beilstein Cross Fire, Sci-Finder,
Reaxys, ISIS and Discovery Gate, Sales Force, CRM.
 Laboratory instrumentation: GC/MS, LCMS, IR, UV/VIS,NMR, TLC, HPLC.
SELECTED PUBLICATIONS, PATENTS ANDPRESENTATION
Available upon request.
AWARDS
Outstanding Performance Award for the delivery of the breakthrough Ramoplanin and LpxC project leads
Vicuron Pharmaceuticals, 2002.
REFERENCES
Hardwin O’Dowd (Research fellow at Vertex) hardwin@hotmail.com (203) 824-3195
Rakesh Jain (Sr. Scientist at Ardelyx Pharma) rjain1956@gmail.com (510) 703-0642
Tim Shiau (Scientist at Verseon) tpshiau@yahoo.com (510) 508-9898
STATUS: US Permanent Resident seeking U.S. citizenship

Contenu connexe

Tendances

BOC Sciences Updated Its Product Catalog of Pharmaceutical Impurity Reference...
BOC Sciences Updated Its Product Catalog of Pharmaceutical Impurity Reference...BOC Sciences Updated Its Product Catalog of Pharmaceutical Impurity Reference...
BOC Sciences Updated Its Product Catalog of Pharmaceutical Impurity Reference...BOC Sciences
 
Quality In Biopharma Press Release
Quality In Biopharma Press ReleaseQuality In Biopharma Press Release
Quality In Biopharma Press ReleaseStewart K. Jason
 
Linked-spls-initial-hcls-presentation-06082012
Linked-spls-initial-hcls-presentation-06082012Linked-spls-initial-hcls-presentation-06082012
Linked-spls-initial-hcls-presentation-06082012Richard Boyce, PhD
 
Chang Updated Resume Aug 2015
Chang Updated Resume Aug 2015Chang Updated Resume Aug 2015
Chang Updated Resume Aug 2015Chang Vangyi
 
SRINIVASAN_AResume(2016) for Linked In
SRINIVASAN_AResume(2016) for Linked InSRINIVASAN_AResume(2016) for Linked In
SRINIVASAN_AResume(2016) for Linked InAloka Srinivasan
 
Competency of natural product chemist
Competency of natural product chemistCompetency of natural product chemist
Competency of natural product chemistKhoirul Ngibad
 
Biosimilars: Regulatory and Clinical Considerations
Biosimilars: Regulatory and Clinical ConsiderationsBiosimilars: Regulatory and Clinical Considerations
Biosimilars: Regulatory and Clinical ConsiderationsCovance
 
Amy Wakeman Resume
Amy Wakeman ResumeAmy Wakeman Resume
Amy Wakeman ResumeAmy Wakeman
 
CCK Dashboard 2019: Shape Knowledge to Navigate Future
CCK Dashboard 2019: Shape Knowledge to Navigate FutureCCK Dashboard 2019: Shape Knowledge to Navigate Future
CCK Dashboard 2019: Shape Knowledge to Navigate FutureObaid Ali / Roohi B. Obaid
 
P_Flanagan_Resume project_managment 23JUN2016
P_Flanagan_Resume project_managment 23JUN2016P_Flanagan_Resume project_managment 23JUN2016
P_Flanagan_Resume project_managment 23JUN2016Patrick Flanagan
 
FDA's GMP Expectations for Phase I and First-in-Man Clinical Trials
FDA's GMP Expectations for Phase I and First-in-Man Clinical TrialsFDA's GMP Expectations for Phase I and First-in-Man Clinical Trials
FDA's GMP Expectations for Phase I and First-in-Man Clinical TrialsGlobalCompliancePanel
 
UCB Domainex Combinatorial Domain Hunting MEK kinase
UCB Domainex Combinatorial Domain Hunting MEK kinaseUCB Domainex Combinatorial Domain Hunting MEK kinase
UCB Domainex Combinatorial Domain Hunting MEK kinasepfallon
 
CCK Dashboard 2019: Microbiology; A Critical Area
CCK Dashboard 2019: Microbiology; A Critical Area CCK Dashboard 2019: Microbiology; A Critical Area
CCK Dashboard 2019: Microbiology; A Critical Area Obaid Ali / Roohi B. Obaid
 

Tendances (19)

ABALL_PDA
ABALL_PDAABALL_PDA
ABALL_PDA
 
BOC Sciences Updated Its Product Catalog of Pharmaceutical Impurity Reference...
BOC Sciences Updated Its Product Catalog of Pharmaceutical Impurity Reference...BOC Sciences Updated Its Product Catalog of Pharmaceutical Impurity Reference...
BOC Sciences Updated Its Product Catalog of Pharmaceutical Impurity Reference...
 
Quality In Biopharma Press Release
Quality In Biopharma Press ReleaseQuality In Biopharma Press Release
Quality In Biopharma Press Release
 
Medicinal chemistry
Medicinal chemistryMedicinal chemistry
Medicinal chemistry
 
B_Hernandez Resume
B_Hernandez ResumeB_Hernandez Resume
B_Hernandez Resume
 
Linked-spls-initial-hcls-presentation-06082012
Linked-spls-initial-hcls-presentation-06082012Linked-spls-initial-hcls-presentation-06082012
Linked-spls-initial-hcls-presentation-06082012
 
Chang Updated Resume Aug 2015
Chang Updated Resume Aug 2015Chang Updated Resume Aug 2015
Chang Updated Resume Aug 2015
 
SRINIVASAN_AResume(2016) for Linked In
SRINIVASAN_AResume(2016) for Linked InSRINIVASAN_AResume(2016) for Linked In
SRINIVASAN_AResume(2016) for Linked In
 
Gaidos Joan.CV
Gaidos Joan.CVGaidos Joan.CV
Gaidos Joan.CV
 
Competency of natural product chemist
Competency of natural product chemistCompetency of natural product chemist
Competency of natural product chemist
 
Jason Gillette CV
Jason Gillette CVJason Gillette CV
Jason Gillette CV
 
Biosimilars: Regulatory and Clinical Considerations
Biosimilars: Regulatory and Clinical ConsiderationsBiosimilars: Regulatory and Clinical Considerations
Biosimilars: Regulatory and Clinical Considerations
 
Amy Wakeman Resume
Amy Wakeman ResumeAmy Wakeman Resume
Amy Wakeman Resume
 
CCK Dashboard 2019: Shape Knowledge to Navigate Future
CCK Dashboard 2019: Shape Knowledge to Navigate FutureCCK Dashboard 2019: Shape Knowledge to Navigate Future
CCK Dashboard 2019: Shape Knowledge to Navigate Future
 
P_Flanagan_Resume project_managment 23JUN2016
P_Flanagan_Resume project_managment 23JUN2016P_Flanagan_Resume project_managment 23JUN2016
P_Flanagan_Resume project_managment 23JUN2016
 
FDA's GMP Expectations for Phase I and First-in-Man Clinical Trials
FDA's GMP Expectations for Phase I and First-in-Man Clinical TrialsFDA's GMP Expectations for Phase I and First-in-Man Clinical Trials
FDA's GMP Expectations for Phase I and First-in-Man Clinical Trials
 
Due diligence
Due diligenceDue diligence
Due diligence
 
UCB Domainex Combinatorial Domain Hunting MEK kinase
UCB Domainex Combinatorial Domain Hunting MEK kinaseUCB Domainex Combinatorial Domain Hunting MEK kinase
UCB Domainex Combinatorial Domain Hunting MEK kinase
 
CCK Dashboard 2019: Microbiology; A Critical Area
CCK Dashboard 2019: Microbiology; A Critical Area CCK Dashboard 2019: Microbiology; A Critical Area
CCK Dashboard 2019: Microbiology; A Critical Area
 

En vedette

The Fianna Fáil
The Fianna FáilThe Fianna Fáil
The Fianna FáilCiara G.
 
Tablas de integrales
Tablas de integralesTablas de integrales
Tablas de integralesSeba Linardi
 
Konferencja- II Forum Strategicznego Wywiadu Biznesowego
Konferencja- II Forum Strategicznego Wywiadu BiznesowegoKonferencja- II Forum Strategicznego Wywiadu Biznesowego
Konferencja- II Forum Strategicznego Wywiadu BiznesowegoSebastian Blazkiewicz
 
Art & Display Mission Statement
Art & Display Mission StatementArt & Display Mission Statement
Art & Display Mission StatementLoren Gundersen
 
The Materiel Readiness of the future 8 Sept 16
The Materiel Readiness of the future 8 Sept 16The Materiel Readiness of the future 8 Sept 16
The Materiel Readiness of the future 8 Sept 16edil66
 
CURRICULUM VITAE trainingsacteren
CURRICULUM VITAE trainingsacterenCURRICULUM VITAE trainingsacteren
CURRICULUM VITAE trainingsacterenEls Schouten
 
Control de calidad
Control de calidadControl de calidad
Control de calidadJesus Huayta
 
Жилищная программа DOM-LAND
Жилищная программа DOM-LANDЖилищная программа DOM-LAND
Жилищная программа DOM-LANDNikolay Gorokhov
 
Entrepreneurship30 150320021537-conversion-gate01
Entrepreneurship30 150320021537-conversion-gate01Entrepreneurship30 150320021537-conversion-gate01
Entrepreneurship30 150320021537-conversion-gate01Oliver COMBASTET
 
Best_of_the_countries_2010
Best_of_the_countries_2010Best_of_the_countries_2010
Best_of_the_countries_2010Khaled Ghozlan
 
Matematika
MatematikaMatematika
MatematikalombkTBK
 
7 Konferencja SASMA Business Security
7 Konferencja SASMA Business Security7 Konferencja SASMA Business Security
7 Konferencja SASMA Business SecuritySebastian Blazkiewicz
 

En vedette (20)

The Fianna Fáil
The Fianna FáilThe Fianna Fáil
The Fianna Fáil
 
Tablas de integrales
Tablas de integralesTablas de integrales
Tablas de integrales
 
Pedersen 2014b
Pedersen 2014bPedersen 2014b
Pedersen 2014b
 
AVAwareness
AVAwarenessAVAwareness
AVAwareness
 
Konferencja- II Forum Strategicznego Wywiadu Biznesowego
Konferencja- II Forum Strategicznego Wywiadu BiznesowegoKonferencja- II Forum Strategicznego Wywiadu Biznesowego
Konferencja- II Forum Strategicznego Wywiadu Biznesowego
 
Bunny storyboard
Bunny storyboard Bunny storyboard
Bunny storyboard
 
Art & Display Mission Statement
Art & Display Mission StatementArt & Display Mission Statement
Art & Display Mission Statement
 
Poliedros
PoliedrosPoliedros
Poliedros
 
The Materiel Readiness of the future 8 Sept 16
The Materiel Readiness of the future 8 Sept 16The Materiel Readiness of the future 8 Sept 16
The Materiel Readiness of the future 8 Sept 16
 
CURRICULUM VITAE trainingsacteren
CURRICULUM VITAE trainingsacterenCURRICULUM VITAE trainingsacteren
CURRICULUM VITAE trainingsacteren
 
Control de calidad
Control de calidadControl de calidad
Control de calidad
 
Reseña maestra
Reseña maestraReseña maestra
Reseña maestra
 
Жилищная программа DOM-LAND
Жилищная программа DOM-LANDЖилищная программа DOM-LAND
Жилищная программа DOM-LAND
 
LAQUA
LAQUALAQUA
LAQUA
 
Bunny storyboard
Bunny storyboard Bunny storyboard
Bunny storyboard
 
Entrepreneurship30 150320021537-conversion-gate01
Entrepreneurship30 150320021537-conversion-gate01Entrepreneurship30 150320021537-conversion-gate01
Entrepreneurship30 150320021537-conversion-gate01
 
Ammu
AmmuAmmu
Ammu
 
Best_of_the_countries_2010
Best_of_the_countries_2010Best_of_the_countries_2010
Best_of_the_countries_2010
 
Matematika
MatematikaMatematika
Matematika
 
7 Konferencja SASMA Business Security
7 Konferencja SASMA Business Security7 Konferencja SASMA Business Security
7 Konferencja SASMA Business Security
 

Similaire à Regulatory Affairs Professional with Drug and Medical Device Experience

Resume_Frederic_Feru_october_2015
Resume_Frederic_Feru_october_2015Resume_Frederic_Feru_october_2015
Resume_Frederic_Feru_october_2015Frederic Feru
 
KristenLBeuving-Word CV(05-15)
KristenLBeuving-Word CV(05-15)KristenLBeuving-Word CV(05-15)
KristenLBeuving-Word CV(05-15)Kristen Beuving
 
Deecher D Cv 3.5.09
Deecher D Cv 3.5.09Deecher D Cv 3.5.09
Deecher D Cv 3.5.09guest20d1ac
 
DDS DRUGS AND DOSAGE FORMS-2020.ppt
DDS DRUGS AND DOSAGE FORMS-2020.pptDDS DRUGS AND DOSAGE FORMS-2020.ppt
DDS DRUGS AND DOSAGE FORMS-2020.pptFakhrulAhsan2
 
Deecher D Cv10.23. 09
Deecher D Cv10.23. 09Deecher D Cv10.23. 09
Deecher D Cv10.23. 09ddeecher
 
Mark a nagy_cv_12_29_15
Mark a nagy_cv_12_29_15Mark a nagy_cv_12_29_15
Mark a nagy_cv_12_29_15Mark Nagy
 
Srinivas Maddi CV _ Prinicipal scientist_ DMPK_ 2015
Srinivas Maddi CV _ Prinicipal scientist_ DMPK_ 2015Srinivas Maddi CV _ Prinicipal scientist_ DMPK_ 2015
Srinivas Maddi CV _ Prinicipal scientist_ DMPK_ 2015Srinivas Maddi
 
Resume and Full CV for RJW_Oct 2015
Resume and Full CV for RJW_Oct 2015Resume and Full CV for RJW_Oct 2015
Resume and Full CV for RJW_Oct 2015Raymond Winquist
 
OscarLara_resume_2015current
OscarLara_resume_2015currentOscarLara_resume_2015current
OscarLara_resume_2015currentOscar Lara
 

Similaire à Regulatory Affairs Professional with Drug and Medical Device Experience (20)

CV SMH 14
CV SMH 14CV SMH 14
CV SMH 14
 
Resume_Frederic_Feru_october_2015
Resume_Frederic_Feru_october_2015Resume_Frederic_Feru_october_2015
Resume_Frederic_Feru_october_2015
 
KristenLBeuving-Word CV(05-15)
KristenLBeuving-Word CV(05-15)KristenLBeuving-Word CV(05-15)
KristenLBeuving-Word CV(05-15)
 
Deecher D Cv 3.5.09
Deecher D Cv 3.5.09Deecher D Cv 3.5.09
Deecher D Cv 3.5.09
 
TWhite CV_Aclairo_Jan 2016
TWhite CV_Aclairo_Jan 2016TWhite CV_Aclairo_Jan 2016
TWhite CV_Aclairo_Jan 2016
 
Krunal_CV
Krunal_CVKrunal_CV
Krunal_CV
 
Krunal_CV
Krunal_CVKrunal_CV
Krunal_CV
 
Krunal_CV
Krunal_CVKrunal_CV
Krunal_CV
 
DDS DRUGS AND DOSAGE FORMS-2020.ppt
DDS DRUGS AND DOSAGE FORMS-2020.pptDDS DRUGS AND DOSAGE FORMS-2020.ppt
DDS DRUGS AND DOSAGE FORMS-2020.ppt
 
Deecher D Cv10.23. 09
Deecher D Cv10.23. 09Deecher D Cv10.23. 09
Deecher D Cv10.23. 09
 
Mark a nagy_cv_12_29_15
Mark a nagy_cv_12_29_15Mark a nagy_cv_12_29_15
Mark a nagy_cv_12_29_15
 
Lionel mascarenhas cv
Lionel mascarenhas cvLionel mascarenhas cv
Lionel mascarenhas cv
 
SC CV 2016
SC CV 2016SC CV 2016
SC CV 2016
 
Showi Babu_Resume
Showi Babu_ResumeShowi Babu_Resume
Showi Babu_Resume
 
Srinivas Maddi CV _ Prinicipal scientist_ DMPK_ 2015
Srinivas Maddi CV _ Prinicipal scientist_ DMPK_ 2015Srinivas Maddi CV _ Prinicipal scientist_ DMPK_ 2015
Srinivas Maddi CV _ Prinicipal scientist_ DMPK_ 2015
 
Anne jan 2016
Anne  jan 2016Anne  jan 2016
Anne jan 2016
 
KC
KCKC
KC
 
UNC Eshelman School of Pharmacy Highlights
UNC Eshelman School of Pharmacy HighlightsUNC Eshelman School of Pharmacy Highlights
UNC Eshelman School of Pharmacy Highlights
 
Resume and Full CV for RJW_Oct 2015
Resume and Full CV for RJW_Oct 2015Resume and Full CV for RJW_Oct 2015
Resume and Full CV for RJW_Oct 2015
 
OscarLara_resume_2015current
OscarLara_resume_2015currentOscarLara_resume_2015current
OscarLara_resume_2015current
 

Regulatory Affairs Professional with Drug and Medical Device Experience

  • 1. Bum Kim, M.S. Suwanee, GA 30024 (510) 709 - 7441 www.linkedin.com/in/bumkim bryantbumkim@yahoo.com OBJECTIVE To pursue a challenging career in Drug, Biologics, and Medical Device Regulatory Affairs and become a part of an esteemed organization where I can use my skills, knowledge and experience to contribute in DMRs,Technical files, Design Dossiers, IND application/EUA documents, CAPA, CMC compilation, QSR’s, ISO, CRFs, Clinical Study Monitoring, ICH/GCP guidelines and Project Planning to the growth of the organization. SUMMARY  Accustomed to working with project teams and providing research and advice on compliance with federallaws and FDA/USDA regulatory agency guidelines, SOP preparation, updated good laboratory practices.  Strong knowledge of Medical Device Reporting (MDRs), Medical Vigilance Reporting (MDVs), risk management, validations, design controls, process development, monitoring, statistical controls and root cause analysis.  Participated in audits performed by internal and external representatives for ISO and FDA compliance.  Familiarity with the drug and medical device development process – cGMP (DMF), GLP, GCP, QSR, IND, NDA, BLA, 510K, PMA, Informed Consent, IRB review, and ethical principles (Belmont Report) in clinical research.  Solid working experience in the pharmaceutical industry – New Drug Discovery Research.  Familiarity with standard concepts, practices, and procedures within a biotech/life sciences field.  Methodical, quick-learner and highly independent team player, problem solver and can troubleshoot any scientific issues.  Ability to multi-task and to establish and maintain good working relationships at all levels.  Strategic thinker with strong attention to detail and with excellent communication skills. EDUCATION Northeastern University Boston, MA Master of Science in Regulatory Affairs September 2015 Concentration in Drugs, Biologics and Medical Devices,GPA: 3.6 (4.0) Relevant Courses: Drug and Medical Device Regulation, Human Experimentation, New Drug Development: Regulatory Overview, Medical Device Development: Regulatory Overview, Food, Drug, & Medical Device Law, Biologics Development: Regulatory Overview, Adv. & Promo of Drugs and Medical Device Products,Clinical Drug Data Analysis. University ofMemphis Memphis, TN Master of Science in Organic Chemistry,GPA: 3.3 (4.0) December 2001 Relevant Courses: Inorganic Chemistry, Advanced Instrumental Analysis, Intermediate Organic Chemistry, Heterocyclic Chemistry, Advanced Organic Chemistry, Physical Chemistry, Advanced Physical Chemistry, Synthetic Organic Chemistry, Advanced Analytical Chemistry, Approximate Chemical Modeling Methods. Activities:  Research Assistant – Studied molecular design and molecular recognition of xanthine based nucleosides leading to the isolation and characterization of xanthine nucleosides.  Teaching Assistant – Taught general chemistry and organic chemistry labs.  Coordinated laboratory materials, conducted lab sessions, and graded lab reports. WORK EXPERIENCE SUPRA SCIENCES Atlanta, GA Technical Sales Scientist June 2015 – Current  Handled Company accounts as a direct line to sales and technical support.  Helped to support regulatory compliance throughout the organization.  Travelled to large pharmaceutical companies and academic institutions for company product presentation and field action activities.
  • 2. CPC SCIENTIFIC Sunnyvale, CA Technical Sales Account Manager March 2013 – May 2014  Managed company’s peptide and research product portfolio.  Performed other job related duties as required, e.g. managing company accounts.  Updated and analyzed strategic accounts within the territory.  Established relationships with clients through phone conversations and compiled a list of valuable accounts. Utilized interpersonal and communication skills to develop these relationships and close the deal. ANASPEC Fremont, CA Technical Inside Sales April 2012 – February 2013  Managed and promoted sales of company’s products; 12,000 catalog proteomics and genomic products (peptides, antibodies, dyes, assay kits, unusual amino acids, q-PCR),as well as custom made products.  Coordinated and ensured quality control process by working with QC/QA dept. – compliance with SOP.  Enhanced organizational effectiveness through inter-dept. relationship (production, purification, QC/QA, Sales & Marketing departments). Worked with multi-national individuals and companies.  Supported the implementation of regulatory activities throughout the facility. NOVABAYPHARMACEUTICALS Emeryville, CA Senior Research Associate March 2008 – September2011  Produced a series of N-Chloroamine analogs (Aganocide) for biological screening and stability leading to the identification of highly broad-spectrum biological activity with excellent stability profile.  Participated in drug design and syntheses of different classes of Anti-infective such as LpxC, DNA Ligase and Oxazolidinone compounds, which resulted in excellent antibacterial activity.  Co-inventor of key patents for Aganocide compounds with NovaBay Pharmaceuticals. CHEMOCENTRYXPHARMACEUTICALS Mountain View, CA Senior Associate Scientist August 2007 – March 2008  Produced first lead series that validated the project, leading to the discovery of highly potent CCR2 chemokine receptors.  Identified early generation of biologically-active chemokine receptor compounds for screening purposes with improved CYP and PK profile by multi-step organic synthesis. SUNESIS PHARMACEUTICALS South San Francisco, CA Staff Research Associate II December 2005 – July 2007  Contributed in design and synthesis of novel kinase inhibitors (Aurora, RAF and BTK) for anti-cancer and anti-inflammatory agents.  Produced key leads with improved potency and safety. PFIZER INC. / VICURON PHARMACEUTICALS Fremont, CA Scientist III March 2003 – November2005  Co-invented key patent on the novel Ramoplanin derivatives possessing antibacterial activity.  Independently designed and implemented multi-step synthetic syntheses of key lead compounds.  Prepared and purified modified natural products (Polymyxin B, Ramoplanin and Pleuromutilin) improved in toxicity profile and biological activity. Scientist II November 2001 – February 2003  Contributed to pre-clinical discovery of novel anti-infective drugs, including antibacterial (Ramoplanin, Pleuromutilin) and antifungal (Polymyxin B) projects.  Analyzed and prepared compounds for screening by multi-step organic synthesis that included the lead compound identification in the project.
  • 3. RELEVANT SKILLS  Languages: Fluent in English and Korean.  Computer skills: Proficient in MS Word, Excel, PowerPoint, MS Project, Beilstein Cross Fire, Sci-Finder, Reaxys, ISIS and Discovery Gate, Sales Force, CRM.  Laboratory instrumentation: GC/MS, LCMS, IR, UV/VIS,NMR, TLC, HPLC. SELECTED PUBLICATIONS, PATENTS ANDPRESENTATION Available upon request. AWARDS Outstanding Performance Award for the delivery of the breakthrough Ramoplanin and LpxC project leads Vicuron Pharmaceuticals, 2002. REFERENCES Hardwin O’Dowd (Research fellow at Vertex) hardwin@hotmail.com (203) 824-3195 Rakesh Jain (Sr. Scientist at Ardelyx Pharma) rjain1956@gmail.com (510) 703-0642 Tim Shiau (Scientist at Verseon) tpshiau@yahoo.com (510) 508-9898 STATUS: US Permanent Resident seeking U.S. citizenship